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Abstract: The mangrove ecosystem is a largely unexplored source for actinomycetes with 
the potential to produce biologically active secondary metabolites. Consequently, we set 
out to isolate, characterize and screen actinomycetes from soil and plant material collected 
from eight mangrove sites in China. Over 2,000 actinomycetes were isolated and of these 
approximately 20%, 5%, and 10% inhibited the growth of Human Colon Tumor 116 cells, 
Candida albicans and Staphylococcus aureus, respectively, while 3% inhibited protein 
tyrosine phosphatase 1B (PTP1B), a protein related to diabetes. In addition, nine isolates 
inhibited aurora kinase A, an anti-cancer related protein, and three inhibited caspase 3, a 
protein related to neurodegenerative diseases. Representative bioactive isolates were 
characterized using genotypic and phenotypic procedures and classified to thirteen genera, 
notably to the genera Micromonospora and Streptomyces. Actinomycetes showing 
cytotoxic activity were assigned to seven genera whereas only Micromonospora and 
Streptomyces strains showed anti-PTP1B activity. We conclude that actinomycetes isolated 
from mangrove habitats are a potentially rich source for the discovery of anti-infection and 
anti-tumor compounds, and of agents for treating neurodegenerative diseases and diabetes.  
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1. Introduction  
 
It is indisputable that new drugs, notably antibiotics, are urgently needed to halt and reverse the 
relentless spread of antibiotic resistant pathogens which cause life threatening infections and risk 
undermining the viability of healthcare systems [1]. Filamentous bacteria belonging to the order 
Actinomycetales, especially Micromomospora and Streptomyces strains, have a unique and proven 
capacity to produce novel antibiotics [2-4], hence the continued interest in screening such organisms 
for new bioactive metabolites [5, 6]. However, it is becoming increasingly difficult to discover 
commercially significant secondary metabolites from well known actinomycetes as this practice leads 
to the wasteful rediscovery of known bioactive compounds, thereby emphasizing the need to isolate, 
characterize and screen reperesentatives of undiscovered actinomycete taxa. It is also becoming 
increasingly clear that un- and under-explored habitats, such as desert biomes and marine ecosystems, 
are a rich source of novel actinomycetes which have the capacity to produce interesting new bioactive 
compounds, including antibiotics [7-10]. 
Molecular ecological studies on community DNA extracted from deep-sea sediments revealed the 
presence of an astonishingly rich diversity of actinomycete taxa, most of which were predicted to 
represent novel species, genera and families [11, 12]. It is not surprising, therefore, that new species of 
known actinomycete genera isolated from marine habitats are being described on a regular basis 
[13-18]. There is also a steady stream of proposals for the recognition of new genera, as exemplified 
by the isolation of the Demequina from tidal mud flats [19], Serinicoccus from surface sea water [20] 
and Salinispora from oceanic sediments [21]. Representatives of these genera have an obligate 
requirement for salt, as do deep sea polar strains of Dietzia and Rhodococcus [22]. It has also been 
shown that nearly 60% of actinomycetes isolated from sediment samples collected from around the 
island of Guam in the Pacific Ocean required seawater for growth [23].  
It is perhaps not surprising that novel marine actinomycetes are proving to be such a valuable source 
of new bioactive compounds [24-26] as actinomycete systematics is providing a taxonomic road map 
to genes hence products, including the discovery of first-in-class drug candidates [9, 27-29]. Indeed, an 
encouraging flow of novel anti-infection and anti-cancer compounds are being sourced from marine 
actinomycetes, as exemplified by the discovery of the abbysomicins, potent polycyclic polyketides 
active against methicillin-resistant Staphylococcus aureus and produced by “Verrucosispora maris” 
[30] and salinosporamide A, an anti-cancer compound produced by Salinispora tropica [31]. Marine 
Verrucosispora strains are also a source of novel proximicins, anti-tumor furan analogues of the 
antibiotic netropsin [32]. 
The discovery of novel microbial natural products is encouraged not only by the quality of 
biological material but also by the novelty of screening models. Many new molecular targets have 
been designed to detect anti-microbial and cytotoxic activities [33], and to highlight chemical entities 
for the treatment of conditions such as diabetes and degenerative diseases. Caspase 3, a key protease 
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involved in programmed cell death of neuronal apoptosis, for instance, is a promising target for the 
treatment of neurodegenerative diseases [34]. Similarly, potent and selective protein tyrosine 
phosphatase 1B inhibitors are potential therapy for the treatment of type-2 diabetes and obesity 
[35-37]. 
Mangroves, unique woody plant communities of intertidal coasts in tropical and subtropical coastal 
regions, are highly productive ecosystems [38, 39] though surprisingly little is known about the 
microbial communities living therein [40-42], although there is evidence that mangrove sediments 
contain high populations of micromonosporae [43] and novel actinomycetes, as illustrated by the 
isolation of Asanoa iriomotensis [44] and Nonomuraea maheshkhaliensis [13]. It is also encouraging 
that bioactive compounds have been obtained from mangrove plants [44-46], fungi [47-50], and 
bacteria [51], including actinomycetes [14, 52]. 
During 2001-2005, “China Sea” and “microorganism” showed the highest percentage of source 
region and source phyla citations, respectively, with respect to the total of marine natural products for 
1965-2005 [24]. The rich mangrove flora of South-East China is composed of 26 plant species which are 
classified into 15 genera and 12 families [39]. All but one of the plant species, including four endemic 
ones, are found in mangroves located around the coast of Hainan Island. The primary aim of the present 
study was to determine whether actinomycetes isolated from environmental samples collected from 
mangrove forests in Fujian, Guangdong, Guangxi and Hainan Provinces in China showed biological 
activities. To this end, a range of selective isolation and characterization procedures were used to 
recover and identify diverse actinomycetes from plant and soil samples prior to establishing their 
activities in a number of biological screening assays. Representative isolates found to be active against 
tumor cells and a diabetes related protein were fully characterized using established chemotaxonomic, 
morphological and molecular systematic methods.  
 
2. Results  
 
2.1 Selective isolation of actinomycetes 
 
A total of 2,041 actinomycetes were isolated from 112 soil and 99 plant samples collected from the 
eight mangrove sites, the average number of isolates per sample was 9.7 (2,041 from 211) (Table 1). 
The highest average number of actinomycetes, 21.8 (1,004 from 46), was obtained from the 
rhizosphere soil samples, and the lowest number, 4.5 (434 from 99), from the plant tissues samples. It 
is apparent that the number of endophytic actinomycetes isolated from plant tissues is much less than 
those recovered from the composite soil samples. The highest average number of isolates were 
obtained from the composite soil samples collected from the Fujian mangrove (93 isolates from 3 
samples), and the lowest number from the corresponding Guangxi sample (62 isolates from 17 
samples). In total, 603 actinomycetes were isolated from the composite soil samples giving an average 
nearly of 9.3 strains per sample. 
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Table 1. Selective isolation of actinomycetes from mangrove environmental samples. 
Sites 
Number of samples / Number of isolated actinomycetes 
Composite 
soil 
Rizhosphere 
soil 
Plant 
tissues 
Total 
Danzhou 5/40  ND ND 5/40 
Fujian 3/93 ND ND 3/93 
Guangxi 17/62 5/27 4/4 26/93 
Haikou 3/25  5/16 2/11  10/52 
Sanya 3/78  ND ND 3/78 
Shenzhen 4/57 5/44 8/48 17/149 
Wenchang 26/205 31/917 62/256  119/1378 
Zhanjiang 5/43 ND 23/115 28/158 
Total 66/603 46/1004 99/434 211/2041 
 
2.2 Bioactivity of strains isolated from the mangrove sites 
 
All of the isolates were examined to determine their activities in five high throughput screening 
models, namely against Human Colon Tumor (HCT) 116 cells, Candida albicans ATCC 10231, 
Staphylococcus aureus ATCC 51650, protein tyrosine phosphatase (PTP1B) and caspase 3. Three 
hundred and forty three strains showed activity against the tumor cell line (16.8%), 198 against S. 
aureus (9.7%), 101 against C. albicans (4.9%), and 59 against PTP1B (2.9%); only 3 isolates inhibited 
caspase 3. In addition, 9 out of the 343 cytotoxic strains showed activity against aurora kinase A, a 
protein related to an indicator of anti-cancer activity. Some of the isolates exhibited activities in more 
than one of the screens.  
Figure 1. Percentage of bioactive strains isolated from composite soil samples 
collected from the mangrove sites. The percentages indicate the number of positive 
hits against each of 4 targets over the total number of strains isolated at each site. 
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The highest percentage of anti-tumor and anti- C. albicans activity was found with strains isolated 
from samples collected from Zhanjiang. Isolates from the Wenchang samples showed activity against 
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all of the screening models, including two out of the three isolates inhibit on caspase 3, possibly 
reflecting the diverse nature of the plant species growing at these well preserved locations (Figure 1). 
In contrast, the lowest number of bioactive strains was recorded from the Guangxi samples; it was 
noted that the soil from this location contained more sand and less organic matter than those from 
other sites. 
It can be seen from Table 2 that a higher percentage of bioactive strains were isolated from the plant 
tissues compared with those isolated from the corresponding rhizosphere soil samples with respect 
strains isolated from the Wenchang samples but with two exceptions of cytotoxicity and PTP1B 
inhibition from the Zhangjiang samples. 
Table 2. Percentage of bioactive strains isolated from plant tissues against those 
isolated from corresponding rhizosphere soil. 
Sampling  
sites 
Sample type  Anti- 
C. albicans 
Anti- 
S. aureus 
Anti- 
tumor cell 
PTP1B  
inhibition 
Wenchang Plant tissues  9.8 16.0 22.2 1.6 
Rhizosphere soil   3.5  8.2 14.4 1.2 
Zhangjiang Plant tissues 20.0 37.4  4.3 / 
Rhizosphere soil 15.0  2.3 25.0 5.0 
 
2.3 Bioactivity of actinomycetes isolated from the 23 mangrove plant species 
 
Higher total number of bioactive actinomycetes was obtained from the rhizosphere soil than from 
plant materials collected from the 23 mangrove plant species with the exception of anti-C. albicans. 
Strains isolated from either the rhizosphere soil or the plant tissues of Acanthus ilicifolius showed 
activity in all of the assays, apart from caspase 3.  
 
Table 3. Number of bioactive actinomycetes isolated from rhizosphere soils and plant 
tissues of 23 mangrove plant species.  
 
 
 
Mangrove plant species  
Number of Bioactive actinomycetes 
Rhizosphere soil   Plant tissues 
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Acanthus ilicifolius  1 5 13 2  6 3 5 3 
Acrostichum aureum  0 0 0 0  2 1 0 0 
Acrostichum speciosum  0 2 7 0  0 2 2 0 
Aegiceras corniculatum  3 15 5 0  5 11 10 0 
Avicennia marina 1 0 0 0  4 7 1 0 
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Table 3. Cont. 
Barringtonia racemosa  0 0 1 0  ND ND ND ND 
Bruguiera gymnorrhiza  2 4 5 0  12 15 6 1 
Bruguiera sexangula  1 2 12 2  0 0 1 0 
Cerbera manghas  5 0 4 3  1 4 4 0 
Ceriops tagal  0 0 0 0  2 1 1 0 
Excoecaria agallocha  0 0 3 0  0 3 2 0 
Heritiera littoralis  13 26 22 2  3 3 2 0 
Hibiscus tilisaceus  6 16 33 4  7 4 7 0 
Kandelia candel  0 0 1 0  2 4 1 0 
Lumnitzera racemosa  0 0 0 0  0 2 2 1 
Pongamia pinnata  0 7 6 0  0 2 2 0 
Rhizophora apiculata  0 2 11 3  0 1 2 0 
Rhizophora stylosa ND ND ND ND  7 14 3 0 
Sonneratia alba  7 12 10 0  0 2 3 0 
Sonneratia caseolaris 1 4 6 1  0 3 4 0 
Sonneratia hainanensis  0 0 0 0  0 0 0 0 
Sonneratia paracaseolaris  2 4 5 0  0 4 1 0 
Xylocarpus granatum 0 0 0 0  4 2 3 0 
Total 42 99 144 17  55 88 62 5 
 
The highest number of bioactive strains was observed from the rhizosphere soil of Heritiera 
littoralis. High numbers of bioactive strains were found in all of the assays, apart from caspase 3, in 
the case of isolates from the rhizosphere soil of Heritiera littoralis, and from the plant tissues of 
Bruguiera gymnorrhiza. In contrast, bioactive actinomycetes were not obtained from the rhizosphere 
soil or the plant tissues of Sonneratia hainanensis, an endemic plant in Hainan mangrove forests 
(Table 3).  
 
2.4 Taxonomic diversity of bioactive actinomycetes 
 
Two hundred and thirty seven isolates selected on the basis of their metabolites bioactivities were 
identified using chemotaxonomic (presence of isomers of diaminopimelic acid and diagnostic 
whole-organism sugars) and morphological (as seen by light microscopy) markers, and by 16S rRNA 
gene sequence data. The results showed that the tested isolates belonged to 13 genera classified into 7 
families and 5 suborders (Table 4). It is clear from the table that the highest activities were shown by 
isolates assigned to the genera Micromonospora and Streptomyces. However, it is also interesting that 
the Actinomadura, Nocardia and Nonomuraea isolates showed anti-tumor cell activity.  
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Table 4. Identification of representative bioactive actinomycetes isolated from Chinese 
mangroves. 
 
Genera Families Suborders Number of the identified 
representative strains 
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Actinomadura Thermomonosporaceae Streptosporangineae   3   
Microbispora      1  
Nonomuraea Streptosporangiaceae    1   
Actinoplanes Micromonosporaceae Micromonosporineae 1     
Micromonospora   7 10 25 1 8 
Verrucosispora     1   
Arthrobacter  Micrococcaceae Micrococcineae  1    
Isoptericola    1     
Micrococcus   1     
Microbacterium Microbacteriaceae  1     
Nocardia Nocardiaceae Corynebacterineae   5   
Rhodococcus    1 1   
Strepomyces Streptomycetaceae Streptomycineae 1 7 45 1 4 
 
2.5 16S rRNA gene sequencing of representative isolates showing activity against tumor cells 
 
The most taxonomically diverse actinomycetes were those showed activity against the tumor cells. It 
can be seen from Figure 2 that the 26 tested strains which gave positive results were assigned to 7 
genera with just over half of them belonging to the genus Streptomyces. Most of the Streptomyces 
isolates formed distinct phyletic lines though strain 172621 was found to have an identical sequence to 
that of the type strain of S. coelicolor. Similarly, the 6 isolates belonging to the genus Micromonospora 
formed a diverse group, as did the 4 Nocardia isolates. It was interesting that the single isolate 
assigned to the genus Actinomadura had an identical 16S rRNA gene sequence to the type strain of A. 
glauciflava. In contrast, the single isolates belonging to the genera Nonomuraea, Rhodococcus, and 
Verrucosispora formed relatively distinct phyletic lines.  
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Figure 2. Neighbor-joining tree based on almost complete 16S rRNA gene sequences 
showing relationships between the 26 selected actinomycetes found to inhibit tumor 
cells in vitro, and between them and the type strains of the highest 16S rDNA 
sequence similarity. Numbers at the nodes indicate bootstrap values based on 1000 
replicates; only values above 50% are shown. Bar, 1% sequence divergence. 
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Some of the Streptomyces isolates were assigned to 16S rRNA subclades which reflected the sites 
from which they were isolated. In particular, the three strains from Wenchang, isolates 061337, 
0614149 and 162227, formed a distinct subclade together with the type strain of S. cheonensis, a taxon 
supported by a 100% bootstrap value. Similarly, isolates 172614 and 172621 from the Shenzhen 
composite soil constituted a well delineated subclade together with the type strains of S. coelicolor and 
S. violaceus. The four strains isolated from the Sanya composite soil sample were part of a more 
diffuse subclade which encompassed the type strains of S. endus, S. griseobrunneus, S. griseus and S. 
psammoticus (Figure 2). Most of the Micromonospora strains which showed activity against tumor 
cells were isolated from the roots of mangrove plants, i.e., Acrostichum aureum (isolate160126), 
Acrostichum speciosum (isolate 160222), Cerbera manghas (isolate 162121), Lumnitzera racemosa 
(isolate 161022) and Rhizophora stylosa (162223). More micromonosporae than streptomycetes were 
isolated from the plant material. 
 
2.6 16S rRNA gene sequences of isolates which inhibited protein tyrosine phosphatase 1B  
 
The 12 actinomycetes those metabolites active in the PTP1B screen were assigned to the genera 
Micromonospora and Streptomyces (Figure 3). Six out of the 8 Micromonospora strains formed 
relatively distinct phyletic lines though isolates 201806 and 215009 had identical 16S rRNA gene 
sequences to one another and to the type strain of M. chalcea. The 4 Streptomyces isolates were 
relatively closely related to the type strains of Streptomyces species. Indeed, isolate 172610 had an 
identical 16S rRNA gene sequence to the type strain of S. albus whereas isolate 216802 had a nearly 
identical sequence to S. violaceochromogenes NBRC 13100T. 
 
3. Discussion 
 
Considerable attention is currently being paid to the isolation and characterization of novel 
actinomycetes from poorly researched habitats given the premise that screening such organisms raises 
the prospect of discovering new natural products that can be developed as a resource for biotechnology 
[7, 10, 43]. This reasoning appears to be sound as novel actinomycetes isolated from unexplored 
marine habitats are proving to be a valuable source of new bioactive metabolites [9, 26]. It seems 
timely, therefore, to extend this approach to another poorly studied environment, the mangrove 
ecosystem. Mangroves develop along estuaries in tropical and subtropical regions where sea water and 
fresh water mix. Indeed, mangrove forests may become an invaluable source for discovering novel 
actinomycetes hence new chemodiversity should salinity prove to be a driver of bacterial diversity as 
proposed by Lozupone and Knight [53].  
It was not intended in the present investigation to assemble a detailed inventory of the kinds of 
actinomycetes found in the mangrove ecosystem or to isolate and characterize novel bioactive 
compounds, but the study was designed to prepare the ground for such studies by isolating, partially 
characterizing and screening a diverse range of actinomycetes. Even so, this investigation does provide 
the most comprehensive survey of culturable actinomycetes present in mangrove forests, a result 
which probably reflects the application of a broad range of selective isolation procedures to many 
environmental samples. 
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Figure 3. Neighbor-joining tree based on nearly complete 16S rRNA gene sequences 
showing relationships between the 12 isolates active in the PIP1B assay and between 
them and the highest 16S rDNA sequence similar Micromonospora and Streptomyces 
species. Bifidobacterium bifidum DSM 20456 T (M38018) was used as the outgroup. 
Numbers at the nodes are percentage bootstrap values based on 1,000 replicates; only 
values 50% or above are given. Bar, 2% sequence divergence. 
 
 
In total, representatives of 13 established actinomycete genera belonging to 7 families and 5 
suborders were recognized out of the bioactive isolates. The presence of predominant numbers of 
Micromonospora and Streptomyces strains amongst the isolates is in line with the results reported by 
Eccleston et al. [43]. Asanoa and Gordonia can be added to the list of genera isolated from mangroves 
though the representatives of these taxa did not show any biological activity from the present screening, 
thus provides further evidence that such organisms are present in the mangrove ecosystem [13, 18]. 
Many of the strains isolated in the present study showed bioactivity against one or more of the 
screening systems, thereby underpinning and extending results from previous studies which showed 
mangroves to be a source of bioactive actinomycetes [14, 43]. Thus, 343 isolates showed activity 
against the tumor cell line (16.8%), 101 against C. albicans ATCC 10231(4.9%), 198 against S. aureus 
ATCC 51650 (9.7%), 59 against PTP1B (2.9%); but only 3 and 9 strains were active against caspase 3, 
and aurora kinase A, respectively. The lower inhibition frequencies of biochemical assays on molecular 
level comparing to growth inhibition assays on cell level are acceptable considering their higher 
 Micromonospora  rifamycinica M105T (AY561829) 
Isolate 204202 (EU437808) 
Isolate 215008 (FJ263417) 
M. matsumotoense IMSNU 22003T (AF152109) 
M. siamensis TT2-4T (AB193565) 
Isolate 215221(FJ263415) 
 Isolate 215009 (FJ263418) 
Isolate 201806 (EU437801) 
M. chalcea DSM 43026T (X92594) 
 Isolate 161022 (EF527847)
M. halophytica DSM 43171T (X92601) 
 Isolate 213425 (FJ263420) 
M. echinofusca DSM 43913T (X92625) 
Isolate 190607 (DQ419522) 
M. echinospora DSM 43816T (X92607) 
 Isolate 201206 (EU437790) 
Streptomyces cheonensis VC-A46T (AY822606)
 S. carpaticus NBRC 15390T (AB184641) 
Isolate 215232(FJ263416) 
S. aculeolatus NBRC 14824T (AB184624) 
 Isolate172610 (EF550503) 
 S. albus DSM 40313T (AJ621602) 
S. massasporeus NBRC 3841T (AB184804) 
S. erythrogriseus NBRC 14601T (AB184605) 
 
 Isolate 216802(FJ267618) 
S. violaceochromogenes NBRC13100T (AB184312) 
 Bifidobacterium bifidum DSM 20456 T (M38018) 
99
100
100
97
99
81
100
93 
88 
100
100
62 
73 
77 
85
100
100 
61
92 
52
62 
70 
0.02
Mar. Drugs 2009, 7 
 
 
34 
selectivity. The most active strains belonged to the genera Micromonospora and Streptomyces. Indeed, 
members of these taxa showed activity against caspase 3 and protein tyrosine phosphatase 1B. In 
contrast, representatives of seven genera, namely Actinomadura, Micromonospora, Nocardia, 
Nonomuraea, Rhodococcus, Streptomyces and Verrucosispora, were active against the tumor cell line.  
The distribution of bioactive actinomycetes showed some relationship to the nature and source of 
the environmental samples. The highest percentage of isolates showing anti-tumor and anti- C. 
albicans activity, for example, were from the Zhangjiang mangrove. Isolates from this site and from 
the mangrove at Wenchang were particularly effective in the anti-infective and anti-cancer assays. 
Similarly, higher numbers of bioactive strains were obtained from rhizosphere samples than from 
corresponding plant materials. The rhizosphere soil from Heritiera littoralis was a particularly rich 
source of bioactive strains. These results are not only interesting but will also guide future 
bioprospecting strategies. 
It is becoming increasingly evident that the taxonomic and metabolic diversity encompassed by 
streptomycetes is remarkable, as new and putatively novel Streptomyces species are being 
continuously isolated from under-researched habitats and shown to be valuable sources of new 
bioactive compounds [8,10,26]. The 16S rRNA gene sequence data acquired in the present study 
provided further evidence of this trend. Thus many of the streptomycetes which showed activity in the 
anti-tumor assay can be assigned to new species as they are separated from the type strains 
phylogenetic neighbors by sequence similarities well below those found between closely related 
Streptomyces species, such as those classified in the S. violaceusniger subclades [27, 28] and S. griseus 
[54]. The highest 16S rDNA sequence similarity to the valid species of Streptomyce violaeus of isolate 
172614 and isolate 210701 were lower than 0.97 as 0.95 and 0.968, respectively. Though the highest 
16S rDNA sequence similarity of isolates of 219820 and 219808 to the type strain of S. 
griseobrunneus NBRC 12775T were a little higher than 0.97, with the values of 0.977 and 0.976, 
respectively, they were highly lower than the similarity of most of the known closely related 
streptomycetes species [54]. Isolates 162227 and 0614149 formed a distinct branch with the highest 
16S rDNA sequence similarity of 0.985 and 0.99, respectively, to the type strain of S. carpaticus 
NBRC15390T, but confirmed to be a new species by the DNA-DNA pairing value lower than 70% 
(data not shown). It is also interesting that some of the Streptomyces isolates were assigned to 16S 
rRNA subclades which corresponded to the sites from which the strains were isolated. These 
observations while tentative might reflect an endemic and /or environmental selection of Streptomyces 
species. In this context, it should be noted that evidence has been presented for niche varieties between 
S. griseus strains [55]. 
It is evident from the 16S rRNA gene sequence data that many of the Micromonospora isolates 
active in the anti-tumor and PTP1B assays belong to putatively new species of this genus. Indeed, this 
also applies to isolates assigned to some of other taxa, such as the genera Rhodococcus, Nomomuraea 
and Verrucosispora, thereby indicating that mangrove habitats are likely to be a good source of rare 
actinomycetes. Taxonomic descriptions of new species discovered in this study will be the subject of 
subsequent publications. At present, detailed conclusions regarding the distribution and ecology of 
actinomycete taxa in mangrove habitats is premature. However, it is clear from the present study that 
actinomycetes isolated from mangrove habitats can be expected to provide high quality biological 
material for high through put biochemical, anti-cancer and anti-infection screening programmes. 
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4. Experimental Section  
 
4.1. Collection of samples 
 
Soil samples were collected from mangrove sites at Danzhou, Haikou, Sanya and Wenchang in 
Hainan Province; Shenzhen and Zhanjiang in Guangdong Province; Xiameng in Fujian Province, and 
Beihai in Guangxi Province (Figure 4). At each location, five soil core samples were collected at a 
depth of 0-30 cm within a 100 m2 area. The soils from each location were bulked and homogenized to 
prepare composite samples. In addition, leaf, stem, roots, and where relevant flowers and fruits, were 
collected together with rhizophere soil from plant species growing in the mangrove forest at Wenchang, 
Hainan Province (Table 5). The soil and plant tissue samples were either examined on the day of 
sampling or on the following day. Samples were stored at 4 °C in the dark prior to examination.  
  
Figure 4. Location of sampling sites. 
 
 
Table 5. Source of plant materials and soils collected from the mangrove forest at 
Wenchang, Hainan Province. 
 
Genus and Species  Samples 
Acanthus ilicifolius  Rhizosphere soil, roots, leaves and flowers 
Acrostichum aureum  
Rhizosphere soil, roots and leaves Acrostichum speciosum  
Aegiceras corniculatum  
Avicennia marina Rhizosphere soil, leaves, and fruit 
Barringtonia racemosa  Rhizosphere soil 
Bruguiera gymnorrhiza  
Rhizosphere soil, roots and leaves 
Bruguiera sexangula  
Cerbera manghas  
Rhizosphere soil, roots, leaves, and fruit 
Ceriops tagal  
Excoecaria agallocha  Rhizosphere soil, roots and leaves 
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Table 5. Cont. 
Heritiera littoralis  Rhizosphere soil, leaves, and fruit 
Hibiscus tilisaceus  Rhizosphere soil, roots and leaves 
Kandelia candel  Rhizosphere soil and leaves 
Lumnitzera racemosa  Rhizosphere soil, roots and leaves 
Pongamia pinnata  Rhizosphere soil and leaves 
Rhizophora apiculata  Rhizosphere soil and leaves, 
Rhizophora stylosa Roots and leaves 
Sonneratia alba  
Rhizosphere soil, leaves, and fruit 
Sonneratia caseolaris 
Sonneratia hainanensis  Rhizosphere soil and leaves 
Sonneratia paracaseolaris  Roots and leaves 
Xylocarpus granatum Roots, leaves, and fruit 
 
4.2. Selective isolation of actinomycetes from environmental samples 
 
Air dried soil samples were sieved to exclude large mineral and organic matter particles then 
ground in a pestle and mortar. Selective pretreatments of the soil samples included dry heat (120 °C, 
60 min) [56], treatments with Chloramine-T [57]; phenol (1.5 %, 30 min at 30 °C) [56]; 0.05 % SDS 
and 6 % yeast extract (40 °C, 200 rpm, 30 min) [56], and wet heat in sterilized sea water (50 °C, 15 
min) [58]. The pretreated soil samples were diluted 1:10 v/v with sterile 1/4 Ringer’s solution and 
serial dilutions prepared down to 10-4. One hundred µL of the 10-1 -10-4 suspensions were spread, in 
triplicate, onto selective isolation media. 
The plant tissues were surface cleaned with sterile water and air-dried in a laminar flow hood. The 
resultant preparations were treated with 75% ethanol for 5 min, then with 0.1% HgCl2 for 15 min, prior 
to washing five times for 5 minutes with sterile 1% Tween 80. Five grams of surface sterilized 
mangrove plant tissues were cut into small pieces, added to 45 mL 50% sterile sea water, and ground 
into smaller pieces using a pestle and mortar. Fractions (100 μL) of the resultant preparations were 
plated, in triplicate, onto selective isolation plates which had been dried for 30 minutes at room 
temperature in a laminar flow cabinet.  
Dilutions of soil and plant tissues were plated out onto one or more of 11 different selective isolation 
media (IM1 to IM11):IM1 (oatmeal agar, ISP meduim3) [59]; oatmeal, 60 g; agar, 15 g; pH 7.2~7.4; 
IM2 (Gause modified medium 1 [60]); soluble starch, 20 g; K2HPO4, 0.5 g; KNO3, 1 g; MgSO4·7H2O, 
0.5 g; agar, 20 g; pH7.4~7.6; IM3 (Raffinose-histidine medium[61]); raffinose, 10 g; L-histidine, 1g; 
MgSO4·7H2O, 0.5 g; FeSO4·7H2O, 0.01 g; K2HPO4, 1g; Bacto-agar, 20.0 g; pH 7.0~7.4; IM4, 1/10 
ATCC 172 medium; glucose, 1 g; soluble starch, 2 g; yeast extract, 0.5 g; CaCO3, 1.5g; agar, 18 g; 
N-Z-amine, 0.5 g; pH 7.0~7.4, and supplemented with a filter sterilized solution of novobiocin (25 
mg/ml); IM5, sea-water agar; sea-water, 1L; agar 18 g; IM6 (Yeast extract-malt estract agar; ISP 
medium 2[59]); yeast extract, 4 g; malt extract, 30 g; glucose, 4 g; agar, 18 g; pH 7.0~7.4; IM7 (Starch 
casein agar [62]); starch, 10 g; casein, 3 g; agar, 18 g; pH 7.0~7.4; IM8 [63]; glucose, 10 g; peptone, 5 
g; tryptone, 3 g; NaCl, 5 g; agar, 15 g; pH 7.0, and supplemented with filter sterilized nalidixic acid 
(10 mg/mL) and novobiocin (10 mg/mL); IM9 (Glucose asparagine agar [58]); glucose, 10g; 
asparagine, 0.5 g; K2HPO4, 0. 5 g; agar, 20 g; pH: 7.2~7.4; IM10 (humic acid -vitamin agar [64]); 
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humic acid, 1.0 g; CaCO3, 0.02 g; Na2HPO4, 0.5 g; KC1, 1.7 g; FeSO4.7H2O, 0.01 g; MgSO4·7H2O, 0.5 
g; agar, 18 g; pH7.2, and supplemented with sterilized vitamins: aminobenzoic acid, inositol, nicotinic 
acid, riboflavin, pantothenic acid, thiamine, vitamin B6 (at 0.5mg) and 0.25 mg of biotin; IM11 
(dextran-histidine-sodium chloride-mineral salts agar[65]); K2HPO4, 2 g; KNO3, 2 g; MgSO4·7H2O, 
0.05 g; CaCO3, 0.02 g; FeSO4·7H2O, 0. 01 g; agar, 18 g; distilled water, 1 L; pH 7.2, and 
supplemented with dextran, 1 %,w/v; L-histidine, 0.1 %, w/v; NaCl, 3 %, w/v; penicillin G (5 iu mL-1), 
and rifampicin (5 µg/mL). All of the media, apart from IM5, were supplemented with 50-100 mg/L 
K2Cr2O7, 50 mg/L cycloheximide and 25-50 mg/L nystatin [66], and made up to one liter with 0.5 L 
sea-water and 0.5 L dH2O.  
The inoculated plates were incubated at 28 °C for one up to twelve weeks. Colonies of 
streptomycete-like and non-streptomycete-like strains growing on the isolation plates were inoculated 
onto IM2 and IM6 plates, respectively, and incubated for 7-10 days at 28 °C. Purified cultures were 
stored either on IM 4 or IM6 agar slants for short term storage and in 20% glycerol at -80 °C for 
long-term storage. 
 
4.3. Preparation of crude extracts  
 
The fermentation medium for primary screening was FM 3 [67]: soluble starch, 20 g; soy powder, 
15 g; yeast extract, 5 g; peptone, 2 g; CaCO3, 4 g; sea salts, 18 g in 1 L distilled water, pH 7.2~7.4. 
Two media were used for re-screening, namely FM 2 [68]; Glucose, 10 g; soluble starch, 30 g; yeast 
powder, 2 g; casein, 4 g; K2SO4, 8 g; MOPS (3-[N-morpholino]propanesulfonic acid), 5 g; sea salts, 18 
g; distilled water, 1 L; pH 7.2-7.4; and FM 17 [69]; Glucose, 20 g; yeast powder, 5 g; casein, 5 g; 
KNO3, 15 g; CaCO3, 4 g; sea salts, 18 g; distilled water, 1 L; pH 7.2-7.4. All three media were 
autoclaved at 121 °C for 20 min. 
Each of 2,041 purified isolates were transferred to a test tube (30 mm×200 mm) which contained 
20 mL of the relevant fermentation medium, and cultured at 200 rpm, at an angle of 45º, for 7-10 days 
at 28 °C. Crude extracts were prepared by adding 60 mL of methanol to each of the cultures and the 
extraction allowed to proceed for 2 weeks. One mL fractions of the resultant extracts were transferred 
to wells in deep 96-well plates, vacuum dried at 60 °C, dissolved in 200 μL DMSO and used in the 
biochemical screens and for cytotoxicity assay against HCT-116 cells. 
 
4.4. Biological assays  
 
Antimicrobial activity. The method used was modified from that of Hong and Xiao [70]. C. albicans 
ATCC 10231 and S. aureus ATCC 51650 were cultured overnight at 30 °C at 200 rpm in YPD medium 
(glucose, 2%; tryptone, 2%; yeast extract, 1%; pH 5.0~5.5) and nutrient broth, respectively. The 
resultant cultures were diluted in the same media to 0.8-1.2×106 CFU/mL, and 100 μL aliquots of this 
inoculum were transferred to individual wells in a 96-well plates. Aliquots (100 μL) of the 
fermentation broth supernatant of each of the isolates (fermented in the media above mentioned, and 
centrifuged at 10,000 rpm at 4 °C) were added to each of the wells. The two culture media were used 
as negative controls, and fluconazole and kanamycin as the positive controls for the anti- C. albicans 
and anti S. aureus assays, respectively. The 96-well plates were shaken at 200 rpm for 24h at 30 °C 
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then assayed using a microplate spectrophotometer (Multiskan Mk3, Finland) at 570 nm. The 
absorbance readings from each well were used to record bioactivities as “+”, “++”, or “+++” for higher 
or equal to 4-6, 6-8 and 8 μg/mL of standard, respectively. Serial dilutions of the antibiotics (128, 64, 
32, 16, 14, 12, 10, 8, 6, 4, 2 and 1 μg/mL) were used to generate standard curves. 
 
Cell growth inhibition assay. Fractions (100 μL) of each cell suspension (30,000 cells/mL) of the 
adherent cell line HCT-116 were dispensed into individual wells in 96-well plates which were 
incubated in McCoy's 5A medium (Sigma-Aldrich Corp., St. Louis, MO) at 37 °C in an incubator 
containing 5% CO2 for 24 hours to allow surface attachment of the cells. Preparation in DMSO (1 μL) 
were added and the 96-well plates incubated under the same conditions for 72 hours when 30 μL MTT 
(5 mg/mL) was added to each of the wells and the plates incubated for 3 hours under the same 
conditions. The media were removed using a pipette and 100 μL DMSO added to each of the wells of 
the plates. Readings were taken using a SpectraMAX340 microplate reader (Molecular Devices, 
Sunnyvale, CA) at an absorbance of 550 nm, and a reference wavelength at 690 nm. Adriamycin was 
used as the positive control. The IC50 value of each inhibitor was calculated in GraphPad Prism 
(GraphPad Software, San Diego, CA) using non-linear regression analysis and a sigmoidal dose 
response (variable slope) equation. Data were presented as mean ± S.D. of >3 independent 
experiments unless.  
 
Biochemical assays. The construction, expression, purification, and enzymatic assays for protein 
tyrosine phosphatase 1B (PTP1B) and caspase 3 were carried following Shi [71] and Du [72], 
respectively. Aurora a [73], a recombinant protein kinase domain (125-391 amino acids according to 
AAH02499) was expressed in an Escherichia coli system; determination of the enzymatic activity was 
achieved using a Z-LYTE kinase assay kit (Invitrogen, Carlsbad, CA ). For primary screening, 2 μL of 
the stock solution of each crude extract (1 mg/mL) in DMSO were transferred into individual wells of 
96-well flat bottom plates to give a final concentration of 20 μg/mL of extract in 2% DMSO. After 
incubation with the enzymes for 15 min, 10 times concentrated substrates were added to initiate the 
enzymatic reaction, and the resultant enzymatic activity normalized against the control (2% DMSO) to 
obtain the inhibition rate of the compound. When the inhibition rate was more than 50% at 20 μg/mL, 
the dose-response inhibition assay of the compound was performed to determine the 50% percentage 
inhibition concentrations (IC50). 
 
4.5 Identification of isolates 
 
Morphological characterization. The presumptive streptomycetes were inoculated onto oatmeal agar 
plates [62] prepared with and without sea salts, and onto peptone-yeast extract-iron agar [59] plates 
and incubated at 28 °C for 3 weeks and 4 days, respectively. After incubation, the oatmeal agar plates 
were examined by eye to record aerial spore mass color, substrate mycelial pigmentation, and the color 
of any diffusible pigments. The peptone-yeast extract-iron agar plates were examined for the 
production of melanin pigments  
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Chemotaxonomy. Biomass was harvested from isolates grown at 28 °C for 3-7 days on IM4 or IM6 
agar plates for streptomycte-like and non-streptomycete-like strains, respectively. Isomers of 
diaminopimelic acid and diagnostic whole-organism sugars were detected by using the procedures 
described by Hasegawa et al. [74].  
 
Extraction of DNA from pure cultures and PCR amplification. Total genomic DNA samples from 243 
representative strains were extracted with the Fast DNA®SPIN Kit used for extracting community 
DNA from soil (Q-BIOgene, USA) using a protocol modified from that of the manufacturer 
( Goodfellow, 2007). In short, approximately 0.5g of each culture was suspended in TE buffer (0.5ml) 
and ribolised for 30s at a speed of 5.5 m/s following the addition of sterile glass beads (0.5g, 100 
mesh). The resultant preparations were extracted with an equal volume of chloroform: iso-amyl 
alcohol (24:1, v/v) and centrifuged at 15,000g for 5min at 4 . The upper aqueous layers, which 
contained the DNA, were transferred to fresh tubes and used as template DNA. The PCR reactions 
were performed in a final volume of 25µl which was composed of template DNA (1µl upper aqueous 
layer), 1.5mM MgCl2, 0.2mM of each dNTP, 200pM of primer Eubac27F and primer Eubac1492R[75], 
and 1U of Taq polymerase with the appropriate reaction buffer under the following conditions: initial 
denaturation at 95 °C for 5 min, followed by 28 cycles of 95 °C for 50 s, annealing at 52 °C for 50s, 
and 72 °C for 90s. The amplification products were separated by gel electrophoresis in 1% agarose 
gels which were stained with GoldviewTM Nucleic Acid Stain (SBC, China). 
 
Cloning, sequencing and phylogenetic analyses. The PCR products were blunt-end ligated to the 
plasmid vector pEGM (Promega, USA) and the ligation products transformed into competent E. coli 
DH5α cells. The resultant clones were sequenced using an ABI 3730 Automated Sequencer (Applied 
Biosystems), and the sequences submitted to the BLAST function of GenBank. The cloned 16S rRNA 
gene sequences were aligned using CLUSTAL-X software [76] in the program BioEdit [77]. A 
neighbor joining [78] phylogenetic tree was generated using MEGA version 4.0 software [79], was 
evaluated in a bootstrap analysis [80] of 1,000 replicates; a distance matrix was generated using 
Kimura’s 2-parameter model [81]. 
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